Veeva Vault EDC Now Available to Streamline Trial Design and Execution
April 25 2017 - 7:03AM
Business Wire
New cloud application delivers a better EDC to
allowclinical data management teams to run the trial they want
Veeva Systems (NYSE: VEEV) today announced the availability of
Veeva Vault EDC to help clinical data management teams better run
clinical trials. Veeva Vault EDC delivers a flexible, modern cloud
application to easily design studies, manage amendments, and
improve the speed and quality of data collection. Veeva is bringing
together EDC and eSource with CTMS and eTMF to provide the
industry’s first and only suite of unified cloud applications to
streamline clinical operations and clinical data management.
“Veeva Vault EDC allows life sciences companies to run the trial
they want, not the trial their technology limits them to,” said
Brian Longo, senior vice president and general manager, Veeva Vault
EDC. “With a modern cloud EDC, clinical teams can reduce cost and
complexity to deliver better data faster and accelerate trial
execution.”
Traditional EDC systems struggle to address the growing
complexity and volume of data in clinical trials. Systems are
difficult to integrate and performance is often slow as large
amounts of data are collected. Study amendments require costly and
time consuming data migrations and system downtime.
Veeva Vault EDC gives clinical data management teams the
flexibility to design complex studies faster and easily manage
amendments with no downtime or data migration. Its modern cloud
architecture easily integrates with other clinical applications and
scales to manage increasing volumes of data. Personalized views and
prioritized tasks focus efforts on the most critical actions.
Clinical trial teams can now build and execute studies with greater
efficiency to speed clinical trials.
Customers can use Veeva Vault EDC as a standalone application or
combine it with electronic source data capture with Vault eSource,
planned for availability in December 2017. Together, Vault EDC and
Vault eSource eliminate the need to transcribe patient data into an
EDC system and cut costly and time-consuming source data
verification by clinical monitors.
Veeva Vault EDC is available today as part of the Veeva Vault
Clinical Suite, which also includes Vault eSource, Vault CTMS,
Vault eTMF, Vault Study Startup, and Vault SiteExchange. The
Veeva Vault Clinical Suite enables life sciences companies to
seamlessly manage all content and data across clinical trials.
To learn more, see an online demonstration of Veeva Vault EDC or
register for the webinar, “How to Get Better Clinical Data Faster,”
on May 18, 2017.
Additional InformationFor more on Veeva Vault EDC, visit:
veeva.com/VaultEDCFor more on how to run the trial you want, visit:
veeva.com/BetterEDCConnect with Veeva on LinkedIn:
linkedin.com/company/veeva-systemsFollow @veevasystems on Twitter:
twitter.com/veevasystemsLike Veeva on Facebook:
facebook.com/veevasystems
About Veeva SystemsVeeva Systems Inc. is a leader in
cloud-based software for the global life sciences industry.
Committed to innovation, product excellence, and customer success,
Veeva has more than 500 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in
Europe, Asia, and Latin America. For more information, visit
veeva.com.
Forward-looking StatementsThis release contains
forward-looking statements, including the market demand for and
acceptance of Veeva’s products and services, the results from use
of Veeva’s products and services, and general business conditions,
particularly in the life sciences industry. Any forward-looking
statements contained in this press release are based upon Veeva’s
historical performance and its current plans, estimates, and
expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this
press announcement. Subsequent events may cause these expectations
to change, and Veeva disclaims any obligation to update the
forward-looking statements in the future. These forward-looking
statements are subject to known and unknown risks and uncertainties
that may cause actual results to differ materially. Additional
risks and uncertainties that could affect Veeva’s financial results
are included under the captions, “Risk Factors” and “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations,” in the company’s filing on Form 10-K for the period
ended January 31, 2017. This is available on the company’s website
at veeva.com under the Investors section and on the SEC’s website
at sec.gov. Further information on potential risks that could
affect actual results will be included in other filings Veeva makes
with the SEC from time to time.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170425005706/en/
Veeva Systems Inc.Roger Villareal,
925-264-8885roger.villareal@veeva.comorVeeva Systems Inc.Lisa
Barbadora, 610-420-3413pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Sep 2023 to Sep 2024